# Gastrointestinal Tumor Research and Treatment
**Type:** Topics
**Canonical URL:** https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/
## Facts
| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the diagnosis and treatment of gastrointestinal stromal tumors (GISTs), including the efficacy and safety of targeted therapies like Imatinib Mesylate and Sunitinib, the role of PDGFRA and KIT mutations in GISTs, consensus approaches for management, surgical considerations, prognostic factors, use of EUS-guided fine needle aspiration, and the significance of succinate dehydrogenase (SDH) deficiency. It also explores the use of PET imaging for response evaluation. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11485 |
| Works | 273 |
## Topic papers all
Showing 15 of 273.
- [Comprehensive molecular characterization of gastric adenocarcinoma](https://scholariq.org/papers/comprehensive-molecular-characterization-of-gastric-adenocarcinoma/)
- [Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors](https://scholariq.org/papers/gain-of-function-mutations-of-c-i-kit-i-in-human-gastrointestinal-stromal-tumors/)
- [Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children](https://scholariq.org/papers/efficacy-of-larotrectinib-in-i-trk-i-fusion-positive-cancers-in-adults-and/)
- [Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer](https://scholariq.org/papers/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer/)
- [Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer](https://scholariq.org/papers/definition-and-grading-of-anastomotic-leakage-following-anterior-resection-of/)
- [NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors](https://scholariq.org/papers/nccn-task-force-report-update-on-the-management-of-patients-with/)
- [Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction](https://scholariq.org/papers/randomized-double-blind-placebo-controlled-phase-iii-trial-of-apatinib-in/)
- [Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction](https://scholariq.org/papers/phase-iii-comparison-of-preoperative-chemotherapy-compared-with/)
- [Intussusception of the bowel in adults: A review](https://scholariq.org/papers/intussusception-of-the-bowel-in-adults-a-review/)
- [Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline](https://scholariq.org/papers/diagnosis-and-management-of-nonvariceal-upper-gastrointestinal-hemorrhage/)
- [A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video)](https://scholariq.org/papers/a-prospective-multicenter-study-of-1111-colorectal-endoscopic-submucosal/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-for/)
- [Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022](https://scholariq.org/papers/endoscopic-submucosal-dissection-for-superficial-gastrointestinal-lesions/)
- [Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial](https://scholariq.org/papers/histopathological-regression-after-neoadjuvant-docetaxel-oxaliplatin/)
- [Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/soft-tissue-sarcoma-version-2-2018-nccn-clinical-practice-guidelines-in-oncology/)
## Topic primary papers
Showing 15 of 57.
- [Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors](https://scholariq.org/papers/gain-of-function-mutations-of-c-i-kit-i-in-human-gastrointestinal-stromal-tumors/)
- [NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors](https://scholariq.org/papers/nccn-task-force-report-update-on-the-management-of-patients-with/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-clinical-practice-guidelines-for/)
- [Familial gastrointestinal stromal tumours with germline mutation of the KIT gene](https://scholariq.org/papers/familial-gastrointestinal-stromal-tumours-with-germline-mutation-of-the-kit-gene/)
- [Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastrointestinal-stromal-tumours-esmo-euracan-genturis-clinical-practice/)
- [Malignant Gastrointestinal Stromal Tumor: Distribution, Imaging Features, and Pattern of Metastatic Spread](https://scholariq.org/papers/malignant-gastrointestinal-stromal-tumor-distribution-imaging-features-and/)
- [Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors](https://scholariq.org/papers/hypothyroidism-after-sunitinib-treatment-for-patients-with-gastrointestinal/)
- [Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment](https://scholariq.org/papers/small-bowel-adenocarcinoma-epidemiology-risk-factors-diagnosis-and-treatment/)
- [Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective Database](https://scholariq.org/papers/malignant-gastrointestinal-stromal-tumors-of-the-small-intestine-a-review-of-50/)
- [Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study](https://scholariq.org/papers/incidence-of-gastrointestinal-stromal-tumours-is-underestimated-results-of-a/)
- [Endoscopic diagnosis of submucosal gastric lesions](https://scholariq.org/papers/endoscopic-diagnosis-of-submucosal-gastric-lesions/)
- [Submucosal endoscopic tumor resection for subepithelial tumors in the esophagus and cardia](https://scholariq.org/papers/submucosal-endoscopic-tumor-resection-for-subepithelial-tumors-in-the-esophagus/)
- [The epidemiology of cancer of the small bowel.](https://scholariq.org/papers/the-epidemiology-of-cancer-of-the-small-bowel/)
- [Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience](https://scholariq.org/papers/neoadjuvant-imatinib-in-locally-advanced-gastrointestinal-stromal-tumors-gist/)
- [Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study](https://scholariq.org/papers/incidence-and-clinicopathologic-features-of-gastrointestinal-stromal-tumors-a/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.